Coronavirus Disease 2019 (COVID-19) Vaccines and Drugs Contract Pharmaceutical Development and Manufacturing Relationships

Coronavirus Disease 2019 (COVID-19) Vaccines and Drugs Contract Pharmaceutical Development and Manufacturing Relationships

Summary

This report is the companion to Contract Manufacturing Service Agreements - Rising Manufacturing Opportunities Driven by Pharmaceutical Pipeline Expansion (July 2020). IT covers contract manufacturing agreements for COVID-19 vaccines and drugs worldwide, across a range of different services and manufacturing scales. It covers clinical and commercial contracts. As COVID-19 pharmaceuticals are being ordered in billions of doses by numerous governments, the number of contract service agreements secured serves as an indicator of a CMO's performance. This report is critical for establishing an understanding of the overall CMO industry as it responds to the challenges and opportunities of the pandemic.

Scope

  • This 52-page report gives an important expert quantitative analysis of the contract manufacturing industry's response to the COVID-19 pandemic. Findings are based on the industry’s most comprehensive databases of the CMO industry (GlobalData’s Databases of Contract Service Providers, Drugs, and Deals).
  • This analysis is primarily driven by the Deals Database, which is continuously updated and reveals manufacturing relationships for Pharma products and the types of services offered. The 23 figures and 6 tables throughout the report illustrate major points and trends. This report is required reading for -
  • CMO executives who must have deep understanding of the COVID-19 vaccine and drug landscape -- both pipeline and marketed -- to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
  • Overview of contract manufacturing agreements worldwide for COVID-19 pharmaceuticals and the levels of outsourcing associated with different services and drug type
  • Detailed view of CDMO performance by contract manufacturing agreement and an assessment of their manufacturing scale
  • Manufacturing agreements are assessed by different molecule types, service type, dose form, facility geography, sponsor company types, and CDMO types.


  • About GlobalData
  • Executive Summary
  • Players
    • Table Figure 1: Leaders and Disruptors: Top Players in Outsourcing COVID-19 Vaccine/Therapeutic Manufacturing
  • Trends
    • Table Top Trends in COVID-19 Contract Manufacturing
  • Industry Analysis
    • Objectives and Methodology
    • Pipeline Therapies and Vaccines
      • Therapies
        • Table Figure 2: Pipeline Therapies in Development for COVID-19
        • Table Promising Pipeline Therapies
      • Vaccines
        • Table Figure 3: Pipeline Vaccines in Development for COVID-19
        • Table Promising Pipeline Vaccines
      • Spotlight on Novavax
      • Clinical Trials
        • Table Figure 4: Clinical Trials of COVID-19 Therapies and Vaccines
    • Marketed Therapies and Vaccines
      • Table Marketed Therapies and Vaccines
  • Value Chain: Contract Manufacturing Service Agreements
    • Table Figure 5: The Contract Manufacturing Value Chain
    • Contract Manufacturing Agreements
      • Table Figure 6: COVID-19 Vaccine and Therapy Contract Manufacturing Agreements
    • Contract Manufacturing Agreement Geography
      • Table Figure 7: Contract Manufacturing Agreements for COVID-19 Vaccines and Therapies - Manufacturing Facility Geography
      • Table Figure 8: Contract Manufacturing Agreements for COVID-19 Vaccines and Therapies - Manufacturing Facility Country
      • Table Figure 9: Contract Manufacturing Agreements for COVID-19 Vaccines - Manufacturing Facility Geography
      • Table Figure 10: Contract Manufacturing Agreements for COVID-19 Therapies - Manufacturing Facility Geography
    • Contract Manufacturing Agreements by Service Type
      • Table Figure 11: COVID-19 Contract Manufacturing Agreements by Molecule Type
      • Table Figure 12: Contract Manufacturing Agreements by Service Type
      • Table Figure 13: Contract Manufacturing Agreements by Dosage Form
      • Table Figure 14: Outsourcing by API/Dose/Packaging
      • Table Figure 15: Count of Services Per Contract
      • Table Figure 16: Contract Manufacturing Agreements – Scale of Services
    • Contract Manufacturing Agreements by Top CDMOs
      • Table Figure 17: Top CDMOs by COVID-19 Contract Service Agreements
      • Table Figure 18: CDMOs with COVID-19 Contract Manufacturing Agreements – by Market Cap
      • Table Figure 19: Market Cap Bands of CDMOs (Therapies vs. Vaccines)
      • Spotlight on Catalent
      • Spotlight on Lonza
      • Spotlight on Emergent
      • Spotlight on National Resilience
    • Contract Manufacturing Agreements by Top Products and Sponsors
      • Table Figure 20: Contract Manufacturing Agreements by Top Products/Sponsors
      • Table Figure 21: Vaccine Contract Volume, Gamaleya and AstraZeneca
    • What It Means
      • Future Agreements
      • Contract Manufacturing Capacity
        • Table Figure 22: Vaccine API Contract Manufacturing Facilities, Worldwide
        • Table Figure 23: Vaccine API Contract Manufacturing Facilities, US
  • Appendix
    • Methodology
    • Bibliography
    • Primary Research – Key Opinion Leaders
    • Further Reading
      • Table Further Reading
  • Companies
    • Table CDMOs with COVID-19 Contract Manufacturing Agreements
  • About the Authors
  • Contact Us

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook